25 June 2021 - AbbVie today announced that the U.S. FDA has informed the company that the FDA will not ...
18 June 2021 - Right now, more than 100,000 Americans are waiting for organ transplants. Due to a lack of ...
11 June 2021 - Prescription Drug User Fee Act goal date extended by three months for further review of submission to ...
11 June 2021 - Incyte announced today that the U.S. FDA has extended the review period for the new drug ...
9 June 2021 - FDA deems new drug application for Zimhi complete and establishes a target action date of 12 November ...
8 June 2021 - Incyte today announced that the U.S. FDA has extended the review period for the supplemental new drug ...
28 May 2021 - Prescription Drug User Fee Act goal date extended by three months to 23 September 2021. ...
20 May 2021 - PDUFA date is 17 October 2021. ...
12 April 2021 - Adamis Pharmaceuticals today provided an update on the status of the company’s new drug application relating ...
8 April 2021 - Provention Bio today announced that the company received a notification on 2 April 2021 from the U.S. ...
7 April 2021 - Pfizer today announced that the U.S. FDA has extended the priority review period for the new ...
6 April 2021 - Eli Lilly and Incyte announced today that the U.S. FDA has extended the review period for ...
2 April 2021 - AbbVie announced that the U.S. FDA has extended the review period for the supplemental new drug application ...
19 March 2021 - Regardless of President Joe Biden’s choice for the next commissioner of the FDA, the Senate Health, Education, ...
17 March 2021 - AbbVie announced that the U.S. FDA has extended the review period for the supplemental new drug application ...